1132-1133 / 1578
•
No consensus on what constituted oligometastatic prostatic cancer (OPM)
•
61% voted for a limited bone and/or lymph nodes as a clinically meaningful definition of OPM
that influences treatment decisions (local ablative treatment of all lesions
±
systemic therapy)
•
10% voted for an oligometastatic definition including only limited lymph node metastases
•
13% voted for patients with a limited number of metastases at any location
•
10% did not believe that oligometastatic prostate cancer exists
as a clinically meaningful
entity
•
Among the believers, 14% voted for ≤2 metastases, 66% for ≤3 metastases, and 20% ≤5
metastases as a cut-off.
Gillessen S, Eur Urology 2017